Valiant Laboratories Limited, a active public limited company, was established on 16 August 2021 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24299MH2021PLC365904. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹54.31 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹338.77 Cr and a net worth of ₹100.49 Cr. Employing 77 professional, Its leadership includes Paresh Shashikant Shah (Cfo), Shantilal Shivji Vora (Director), Sandeep Gupta (Director). Past directors included Velji Karamshi Gogri, Shantilal Shivji Vora, Saloni Mehta. It holds ₹62.40 Cr open charges and ₹52.00 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 104,Udyog Kshetra,Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, 400080.
L24299MH2021PLC365904
365904
16 August 2021
₹60.00 Cr
₹54.31 Cr
Roc Mumbai
Listed
Active
Explore comprehensive insights into Valiant Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paresh Shashikant Shah | Cfo | 06 Feb 2022 | Current |
| Shantilal Shivji Vora | Director | 16 Aug 2021 | Current |
| Sandeep Gupta | Director | 23 Feb 2023 | Current |
| Sonal Amit Vira | Director | 16 Feb 2022 | Current |
| Ashok Lakhamshi Chheda | Director | 12 Nov 2024 | Current |
| Santosh Shantilal Vora | Managing Director | 16 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Feb 2022 | Past |
| Pramod Abcsdd | Director | 20 Feb 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 12 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 21 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 18 Dec 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Valiant Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.39% increase. The company also saw a substantial improvement in profitability, with a 27.66% increase in profit. The company's net worth Soared by an impressive increase of 40.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Valiant Laboratories had a promoter holding of 61.84% and a public holding of 38.16%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹624,000,000.00
₹520,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2025 | The Hongkong And Shanghai Banking Corporation Limited | ₹1.00 Cr | Open |
| 08 Jun 2024 | The Hongkong And Shanghai Banking Corporation Limited | ₹4.40 Cr | Open |
| 28 Feb 2024 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 Cr | Open |
| 23 Sep 2022 | Others | ₹52.00 Cr | Open |
| 14 Oct 2022 | Others | ₹52.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Valiant Laboratories has a workforce of 77 employees as of Apr 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Valiant Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valiant Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Valiant Laboratories Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was documented.
The activity A charge with Others of Rs. 52.00 Cr registered on 23 Sep 2022 with Charge ID 100617061 was modified on 04 Sep 2025. was completed.
Akshay Dnyaneshwar Gangurde was appointed as a Company Secretary was appointed as a Company Secretary on 17 Jul 2025 & has been associated with this company since 5 months 25 days . was recorded as a recent event.
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.00 Cr with Charge ID 101111471 was registered on 29 May 2025. was recorded as a recent event.
Progress on Valiant Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Ashok Lakhamshi Chheda was appointed as a Director was appointed as a Director on 12 Nov 2024 & has been associated with this company since 1 year 1 month . was completed.
Valiant Laboratories IPO GMP: Grey market is signaling that Valiant Laboratories share price may open around ₹162 per share levels, say market observers.
Valiant Laboratories IPO subscribed 2.19 times on day 3, with retail investors portion subscribed 3.14 times and NII portion subscribed 1.52 times..
Valiant Labs IPO is now open for subscription! It's worth ₹152.46 crores and has no offer for sale. The company specializes in making Paracetamol and has a research facility in Maharashtra. But experts say it's not a good investment. Better to wait for long-term rewards. #IPO #ValiantLabs #NotWorthIt.
Valiant Laboratories IPO opens tomorrow, offering shares at a price range of ₹133-140..
The CIN of Valiant Laboratories Limited is L24299MH2021PLC365904.
Valiant Laboratories Limited is headquartered at 104,Udyog Kshetra,Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, 400080.
Valiant Laboratories Limited was incorporated on 16 August 2021.
The current directors of Valiant Laboratories Limited are
The primary industry of Valiant Laboratories Limited is Manufacturing.
Valiant Laboratories Limited is listed.
The authorized capital of Valiant Laboratories Limited is ₹60.00 Cr, and the paid-up capital is ₹54.31 Cr.
The compliance status of Valiant Laboratories Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX